Trump staffers reportedly tried to 'shamelessly' jump the COVID-19 vaccine line

Trump administration staffers at almost every professional level "shamelessly" attempted to jump the COVID-19 vaccine line in the early stages of the national drive late last year, a senior administration official told Vanity Fair. It reportedly didn't matter how healthy they were, if they were working home, or how seriously they took pandemic precautions before the shots were available. The requests were coming through.
It's unclear who and how many people were successful in their efforts to get vaccinated within the administration, but Vanity Fair notes that many of them ran into a wall. "It ain't happening" was a common response to the requests, another senior administration official said. That was in part because former President Donald Trump made it clear White House employees should wait their turn. Still, the attempts appear to be representative of the administration's confusing, arbitrary process to vaccinate federal workers.
The plan, spearheaded by the National Security Council, was initially carefully thought out and involved months of deliberations over which federal workers should be prioritized. Ultimately, though, the strategy turned into a "boondoggle," per Vanity Fair, with much of the blame directed at Gen. Gus Perna, who was in charge of vaccine allocation logistics. Perna reportedly scuttled much of the original plan and instead reportedly declared that any federal agency that wanted a supply of shots had to brief him in person. Some with knowledge of the process reportedly believe the change came after Perna realized he could not meet commitments he made to states, forcing him to try to whittle down the number of eligible federal employees. Read more at Vanity Fair.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
There is a 'third state' between life and death
Under the radar Cells can develop new abilities after their source organism dies
By Devika Rao, The Week US Published
-
Is it worth getting an interest-only mortgage?
The Explainer Your monthly payments may be cheaper but the full mortgage amount will need to be paid back eventually
By Marc Shoffman, The Week UK Published
-
Sudoku medium: March 6, 2025
The Week's daily medium sudoku puzzle
By The Week Staff Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published